Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Clinical trial NCT06196827 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06196827
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-02
- Primary completion
- 2023-12-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.